Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TechnipFMC (FTI) Cash & Equivalents (2016 - 2025)

TechnipFMC (FTI) has disclosed Cash & Equivalents for 11 consecutive years, with $1.0 billion as the latest value for Q4 2025.

  • On a quarterly basis, Cash & Equivalents fell 10.87% to $1.0 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $1.0 billion, a 10.87% decrease, with the full-year FY2025 number at $1.0 billion, down 10.87% from a year prior.
  • Cash & Equivalents was $1.0 billion for Q4 2025 at TechnipFMC, up from $876.6 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $1.3 billion in Q4 2021 to a low of $522.3 million in Q1 2023.
  • A 5-year average of $891.1 million and a median of $865.8 million in 2021 define the central range for Cash & Equivalents.
  • Peak YoY movement for Cash & Equivalents: crashed 75.64% in 2021, then skyrocketed 70.32% in 2025.
  • TechnipFMC's Cash & Equivalents stood at $1.3 billion in 2021, then dropped by 20.36% to $1.1 billion in 2022, then dropped by 9.97% to $951.7 million in 2023, then rose by 21.65% to $1.2 billion in 2024, then decreased by 10.87% to $1.0 billion in 2025.
  • Per Business Quant, the three most recent readings for FTI's Cash & Equivalents are $1.0 billion (Q4 2025), $876.6 million (Q3 2025), and $950.0 million (Q2 2025).